Literature DB >> 1081603

Identification of complement-receptor lymphocytes (B cells) in lymph nodes and tumor infiltrates.

W J Catalona, R Mann, F Nime, C Potvin, J I Harty, D Gomolka, J C Eggleston.   

Abstract

To monitor the distribution of lymphocyte sub-populations infiltrating tumors, a simplified modification of standard techniques was developed to identify the complement-receptor B lymphocytes in frozen tissue sections. This technique is based on binding of antibody-coated bovine erythrocytes by B lymphocytes in the presence of sub-hemolytic concentrations of mouse complement. B lymphocytes can be identified in frozen tissue sections by adherent sensitized bovine erythrocytes. The specificity of the technique for B lymphocytes was established by 1) absence of spontaneous rosette formation with bovine erythrocytes by human T lymphocytes, 2) specific binding of bovine erythrocyte-antibody-complement complexes to B cell regions of normal lymph nodes and spleen and 3) binding of erythrocyte-antibody-complement to a high proportion of chronic lymphocytic leukemia (a B cell leukemia) lymphocytes. Five transitional carcinomas studied had regions of mononuclear infiltration that were virtually devoid of complement-receptor lymphocytes. The results suggest that lymphocytes infiltrating bladder carcinomas may be predominantly T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081603     DOI: 10.1016/s0022-5347(17)67174-x

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Prophylaxis of FANFT induced bladder tumours in rats by intravesical DNCB instillation.

Authors:  D K Johnson; J E Pontes; R Izbicki; J M Pierce
Journal:  Urol Res       Date:  1980

2.  Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma.

Authors:  Miao Mo; Xiheng Hu; Wei He; Xiongbing Zu; Long Wang; Yangle Li
Journal:  Transl Androl Urol       Date:  2021-01

3.  The tumor microenvironment: the making of a paradigm.

Authors:  Isaac P Witz
Journal:  Cancer Microenviron       Date:  2009-08-23

4.  Immune response to sipuleucel-T in prostate cancer.

Authors:  Eddie Thara; Tanya B Dorff; Monica Averia-Suboc; Michael Luther; Mary E Reed; Jacek K Pinski; David I Quinn
Journal:  Cancers (Basel)       Date:  2012-04-18       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.